Ortho Development Strengthens Sales Leadership Amid Strategic Growth Plans Ortho Development Corporation elevates its sales leadership team with new appointments, aiming to enhance strategic growth within the orthopedic industry.

Ortho Development Strengthens Sales Leadership Amid Strategic Growth Plans #USA #Orthopedic_Implants #Draper #Sales_Leadership #Ortho_Development

Knee Replacement Market Insights for 2031: Growth Tracking at 4.38% CAGR Driven by Advanced Technology The knee replacement market is projected to grow steadily, reaching USD 15.92 billion by 2031 with a CAGR of 4.38%. Explore key factors driving this expansion.

Knee Replacement Market Insights for 2031: Growth Tracking at 4.38% CAGR Driven by Advanced Technology #India #Knee_Replacement #Orthopedic_Implants #Hyderabad #Joint_Surgery

Tuukka Paavola Takes the Helm as CFO of Bioretec to Drive Financial Strategies Bioretec, a leader in absorbable orthopedic implants, welcomes Tuukka Paavola as CFO. His extensive finance experience will shape the company's growth.

Tuukka Paavola Takes the Helm as CFO of Bioretec to Drive Financial Strategies #Bioretec #Finland #Tampere #Orthopedic_Implants #Tuukka_Paavola

Bioretec Ltd Unveils Financial Reporting Schedule and AGM for 2026 Bioretec Ltd outlines key dates for its financial reports and Annual General Meeting in 2026, highlighting advancements in orthopedic care.

Bioretec Ltd Unveils Financial Reporting Schedule and AGM for 2026 #Bioretec #Finland #Tampere #Orthopedic_Implants #RemeOs

Bioretec's Bold Strategic Overhaul: Paving the Way to 2028 Success Bioretec Ltd unveils its updated strategy for 2026-2028, targeting sales growth and innovation with ambitious financial goals to shape the future of orthopedic implants.

Bioretec's Bold Strategic Overhaul: Paving the Way to 2028 Success #Bioretec #Finland #Tampere #Orthopedic_Implants #RemeOs

HAPPE Spine's INTEGRATE®-C System Transforms Lives of Over 1,000 Patients HAPPE Spine's innovative biomaterial, the INTEGRATE®-C Interbody Fusion System, has successfully treated over 1,000 patients, showcasing its potential in spinal health.

HAPPE Spine's INTEGRATE®-C System Transforms Lives of Over 1,000 Patients #USA #Grand_Rapids #Orthopedic_Implants #HAPPE_Spine #INTEGRATE-C

Bioretec in Strategic Shift to Improve Efficiency and Competitiveness Bioretec Ltd is set to engage in change negotiations aimed at boosting operational efficiency and enhancing competitiveness as it restructures its functions.

Bioretec in Strategic Shift to Improve Efficiency and Competitiveness #Bioretec #Finland #Tampere #Orthopedic_Implants #RemeOs

4WEB Medical Introduces Cutting-Edge Implant Technology for Enhanced Healing 4WEB Medical's recent study reveals groundbreaking therapeutic effects of its TRUSS Implant Technology, paving the way for enhanced healing.

4WEB Medical Introduces Cutting-Edge Implant Technology for Enhanced Healing #United_States #Frisco #Orthopedic_Implants #4WEB_Medical #TRUSS_Implant_Technology

Bioretec's RemeOs™ Screw Receives CMS Pass-Through Payment Approval Bioretec announces that its RemeOs™ Screw has received Transitional Pass-Through Payment approval from CMS, enhancing its orthopedic offerings.

Bioretec's RemeOs™ Screw Receives CMS Pass-Through Payment Approval #RemeOs™ #Bioretec #Finland #Tampere #Orthopedic_Implants

Bioretec Welcomes Dr. Christopher W. DiGiovanni to Scientific Advisory Board to Elevate Orthopedic Innovations Bioretec Ltd. has appointed Dr. Christopher W. DiGiovanni to its Scientific Advisory Board, enhancing its commitment to orthopedic innovation with his expertise.

Bioretec Welcomes Dr. Christopher W. DiGiovanni to Scientific Advisory Board to Elevate Orthopedic Innovations #Bioretec #Finland #Tampere #Orthopedic_Implants #Dr._DiGiovanni

Bioretec Announces Sarah van Hellenberg Hubar-Fisher as New CEO to Drive Growth Bioretec Ltd. has appointed Sarah van Hellenberg Hubar-Fisher as the new CEO, aiming to expand their market presence in absorbable orthopedic implants.

Bioretec Announces Sarah van Hellenberg Hubar-Fisher as New CEO to Drive Growth #Bioretec #Finland #Tampere #Orthopedic_Implants #Sarah_van_Hellenberg

Bioretec Welcomes Sarah van Hellenberg Hubar-Fisher as New CEO to Drive Growth in Orthopedic Innovations Bioretec Ltd. announces Sarah van Hellenberg Hubar-Fisher as its new CEO, aiming to enhance the company's orthopedic technology footprint and innovation.

Bioretec Welcomes Sarah van Hellenberg Hubar-Fisher as New CEO to Drive Growth in Orthopedic Innovations #Bioretec #Finland #Tampere #Orthopedic_Implants #Sarah_van_Hellenberg

The Medical Ceramics Market: Projected to Hit $29.93 Billion by 2032 The global medical ceramics market is set to reach $29.93 billion by 2032, propelled by innovations in implant technology and drug delivery systems.

The Medical Ceramics Market: Projected to Hit $29.93 Billion by 2032 #United_States #Redding #Orthopedic_Implants #Drug_Delivery #Medical_Ceramics

Bioretec Ltd Successfully Completes Oversubscribed Rights Issue Raising Over €9 Million Bioretec Ltd's recent rights issue concluded with an oversubscription of 124.4%, raising approximately €9.2 million for expansion and development.

Bioretec Ltd Successfully Completes Oversubscribed Rights Issue Raising Over €9 Million #RemeOs™ #Finland #Tampere #Orthopedic_Implants #Bioretec_Ltd

Sarah van Hellenberg Hubar-Fisher Takes Helm as Interim CEO of Bioretec In a pivotal move, Bioretec has appointed Sarah van Hellenberg Hubar-Fisher as its interim CEO, marking a new era for the medical device company focused on absorbable orthopedic implants.

Sarah van Hellenberg Hubar-Fisher Takes Helm as Interim CEO of Bioretec #Bioretec #Finland #Tampere #Orthopedic_Implants #Sarah_van_Hellenberg

4WEB Medical Celebrates Groundbreaking 100,000 Spine Procedures Milestone with TRUSS Implant Success 4WEB Medical, a leader in orthopedic implants, proudly announces reaching the significant milestone of 100,000 spine procedures using their innovative TRUSS Implant Technology™.

4WEB Medical Celebrates Groundbreaking 100,000 Spine Procedures Milestone with TRUSS Implant Success #United_States #Dallas #Orthopedic_Implants #4WEB_Medical #TRUSS_Implant

Bioretec Ltd Reports Significant Shareholding Change by WM GmbH under Securities Market Act Bioretec Ltd announces a significant update regarding WM GmbH's shareholding, revealing they now hold 5.78% of the company as of March 14, 2025.

Bioretec Ltd Reports Significant Shareholding Change by WM GmbH under Securities Market Act #Bioretec #Finland #Tampere #Orthopedic_Implants #WM_GmbH

Bioretec Ltd's 2024 Financial Statements: A Step Towards Innovative Medical Solutions Bioretec Ltd has released its 2024 Financial Statements showcasing advancements in absorbable orthopedic implants, signaling promising growth.

Bioretec Ltd's 2024 Financial Statements: A Step Towards Innovative Medical Solutions #Bioretec #Finland #Tampere #Orthopedic_Implants #RemeOs

Bioretec Ltd Releases 2024 Financial Statements Showing Growth and Innovation in Orthopedic Solutions Bioretec Ltd has published its 2024 financial statements, showcasing significant advancements in absorbable orthopedic implants and strong market positioning.

Bioretec Ltd Releases 2024 Financial Statements Showing Growth and Innovation in Orthopedic Solutions #Bioretec #Finland #Tampere #Orthopedic_Implants #RemeOs

Global Orthopedic Implants Market Projected to Reach $26.47 Billion by 2029 Driven by Increasing Demand and Technological Advances The global orthopedic implants market aims to grow from $20.94 billion in 2024 to $26.47 billion by 2029, fueled by technological advancements and increasing orthopedic disorders.

Global Orthopedic Implants Market Projected to Reach $26.47 Billion by 2029 Driven by Increasing Demand and Technological Advances #United_States #Delray_Beach #MarketsandMarkets #Orthopedic_Implants #Stryker_Corporation